Product References
BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway.
Journal of cell communication and signaling
Guo Y,Xu H,Huang M,Ruan Y
Fri Sep 01 00:00:00 EDT 2023
BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway.
Journal of cell communication and signaling
Guo Y,Xu H,Huang M,Ruan Y
Fri Sep 01 00:00:00 EDT 2023
BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway.
Journal of cell communication and signaling
Guo Y,Xu H,Huang M,Ruan Y
Fri Sep 01 00:00:00 EDT 2023
Clinicopathological features and immunophenotype of Silva pattern system in endocervical adenocarcinoma.
International journal of experimental pathology
Zeng C,Wu JK,Lu X
Thu Jun 01 00:00:00 EDT 2023
Nucleophilic covalent ligand discovery for the cysteine redoxome.
Nature chemical biology
Fu L,Jung Y,Tian C,Ferreira RB,Cheng R,He F,Yang J,Carroll KS
Mon May 29 00:00:00 EDT 2023
Nucleophilic covalent ligand discovery for the cysteine redoxome.
Nature chemical biology
Fu L,Jung Y,Tian C,Ferreira RB,Cheng R,He F,Yang J,Carroll KS
Mon May 29 00:00:00 EDT 2023
Nucleophilic covalent ligand discovery for the cysteine redoxome.
Nature chemical biology
Fu L,Jung Y,Tian C,Ferreira RB,Cheng R,He F,Yang J,Carroll KS
Mon May 29 00:00:00 EDT 2023
RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.
Biochemical and biophysical research communications
Zheng L,Chen X,Yin Q,Gu J,Chen J,Chen M,Zhang Y,Dong M,Jiang H,Yin N,Chen H,Li X
Tue Dec 20 00:00:00 EST 2022
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Cancer cell international
Liu S,Zhang Y,Cui S,Song D,Li B,Chen Q,Yao G,Gong B
Sat Nov 13 00:00:00 EST 2021
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Cancer cell international
Liu S,Zhang Y,Cui S,Song D,Li B,Chen Q,Yao G,Gong B
Sat Nov 13 00:00:00 EST 2021
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Cancer cell international
Liu S,Zhang Y,Cui S,Song D,Li B,Chen Q,Yao G,Gong B
Sat Nov 13 00:00:00 EST 2021
NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma.
Frontiers in cell and developmental biology
Zhang YW,Chen Q,Li B,Li HY,Zhao XK,Xiao YY,Liu S,Zuo S
Tue Aug 10 00:00:00 EDT 2021
LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.
Human cell
Ma Q,Qi X,Lin X,Li L,Chen L,Hu W
Wed Jan 01 00:00:00 EST 2020
HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.
Oncology letters
Jiang H,Fu Q,Song X,Ge C,Li R,Li Z,Zeng B,Li C,Wang Y,Xue Y,Luo R,Fang W
Fri Nov 01 00:00:00 EDT 2019
Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
Pathology, research and practice
Liu X,Ma W,Ma J,Xiao L,Hao D
Thu Aug 01 00:00:00 EDT 2019
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Molecular oncology
Min X,Wen J,Zhao L,Wang K,Li Q,Huang G,Liu J,Zhao X
Sat Sep 01 00:00:00 EDT 2018
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Molecular oncology
Min X,Wen J,Zhao L,Wang K,Li Q,Huang G,Liu J,Zhao X
Sat Sep 01 00:00:00 EDT 2018
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Molecular oncology
Min X,Wen J,Zhao L,Wang K,Li Q,Huang G,Liu J,Zhao X
Sat Sep 01 00:00:00 EDT 2018
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Molecular oncology
Min X,Wen J,Zhao L,Wang K,Li Q,Huang G,Liu J,Zhao X
Sat Sep 01 00:00:00 EDT 2018
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Molecular oncology
Min X,Wen J,Zhao L,Wang K,Li Q,Huang G,Liu J,Zhao X
Sat Sep 01 00:00:00 EDT 2018
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Molecular oncology
Min X,Wen J,Zhao L,Wang K,Li Q,Huang G,Liu J,Zhao X
Sat Sep 01 00:00:00 EDT 2018
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Molecular oncology
Min X,Wen J,Zhao L,Wang K,Li Q,Huang G,Liu J,Zhao X
Sat Sep 01 00:00:00 EDT 2018
Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Cell biochemistry and function
Yang GY,Zhang AQ,Wang J,Li CH,Wang XQ,Pan K,Zhou C,Dong JH
Wed Jun 01 00:00:00 EDT 2016
Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Cell biochemistry and function
Yang GY,Zhang AQ,Wang J,Li CH,Wang XQ,Pan K,Zhou C,Dong JH
Wed Jun 01 00:00:00 EDT 2016
Proteomic analysis of cell proliferation in a human hepatic cell line (HL-7702) induced by perfluorooctane sulfonate using iTRAQ.
Journal of hazardous materials
Cui R,Zhang H,Guo X,Cui Q,Wang J,Dai J
Tue Dec 15 00:00:00 EST 2015
Proteomic analysis of cell proliferation in a human hepatic cell line (HL-7702) induced by perfluorooctane sulfonate using iTRAQ.
Journal of hazardous materials
Cui R,Zhang H,Guo X,Cui Q,Wang J,Dai J
Tue Dec 15 00:00:00 EST 2015
Downregulation of the expression of HDGF attenuates malignant biological behaviors of hilar cholangiocarcinoma cells.
Molecular medicine reports
Liu Y,Sun J,Yang G,Liu Z,Guo S,Zhao R,Xu K,Wu X,Zhang Z
Tue Sep 01 00:00:00 EDT 2015
Downregulation of the expression of HDGF attenuates malignant biological behaviors of hilar cholangiocarcinoma cells.
Molecular medicine reports
Liu Y,Sun J,Yang G,Liu Z,Guo S,Zhao R,Xu K,Wu X,Zhang Z
Tue Sep 01 00:00:00 EDT 2015
High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Disease markers
Wang L,Jiang Q,Hua S,Zhao M,Wu Q,Fu Q,Fang W,Guo S
Mon Jan 19 00:00:00 EST 2015
High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Disease markers
Wang L,Jiang Q,Hua S,Zhao M,Wu Q,Fu Q,Fang W,Guo S
Mon Jan 19 00:00:00 EST 2015
Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.
Medical oncology (Northwood, London, England)
Li D,Han Z,Liu J,Zhang X,Ren J,Yan L,Liu H,Xu Z
Sun Dec 01 00:00:00 EST 2013
Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.
Medical oncology (Northwood, London, England)
Li D,Han Z,Liu J,Zhang X,Ren J,Yan L,Liu H,Xu Z
Sun Dec 01 00:00:00 EST 2013
Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
World journal of surgery
Han Y,Zhang W,Liu Y
Tue Oct 01 00:00:00 EDT 2013
Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.
Annals of surgical oncology
Liu YF,Zhao R,Guo S,Wang XQ,Lian PL,Chen YG,Xu KS
Tue Mar 01 00:00:00 EST 2011
Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.
Annals of surgical oncology
Liu YF,Zhao R,Guo S,Wang XQ,Lian PL,Chen YG,Xu KS
Tue Mar 01 00:00:00 EST 2011
Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
Histopathology
Wang S,Fang W
Sat Jan 01 00:00:00 EST 2011
Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
Histopathology
Wang S,Fang W
Sat Jan 01 00:00:00 EST 2011
Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Diagnostic pathology
Zhou Y,Zhou N,Fang W,Huo J
Thu Sep 16 00:00:00 EDT 2010
Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Diagnostic pathology
Zhou Y,Zhou N,Fang W,Huo J
Thu Sep 16 00:00:00 EDT 2010
Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Diagnostic pathology
Zhou Y,Zhou N,Fang W,Huo J
Thu Sep 16 00:00:00 EDT 2010
Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Diagnostic pathology
Zhou Y,Zhou N,Fang W,Huo J
Thu Sep 16 00:00:00 EDT 2010
Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
European journal of cancer (Oxford, England : 1990)
Li YL,Ye F,Cheng XD,Hu Y,Zhou CY,Lü WG,Xie X
Thu Jul 01 00:00:00 EDT 2010
Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
European journal of cancer (Oxford, England : 1990)
Li YL,Ye F,Cheng XD,Hu Y,Zhou CY,Lü WG,Xie X
Thu Jul 01 00:00:00 EDT 2010
transcription cofactor
